Cite
MLA Citation
J.‐F. Yale et al.. “Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.” Diabetes, obesity & metabolism, vol. 15, no. 5, n.d., pp. 463–473. http://access.bl.uk/ark:/81055/vdc_100024477884.0x000011